Login / Signup

Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU).

Michael K HehirMark ConawayAvery B St SauveurKendall FebNoah Allan KolbWaqar WaheedBrendan L McNeishNicole TweedyTed M Burns
Published in: Muscle & nerve (2023)
Our data demonstrate preliminary feasibility and validity of using the AEU to measure AE burden in MG. Future studies will compare AE burden among MG treatments and evaluate clinically meaningful AEU scores in MG.
Keyphrases
  • myasthenia gravis
  • risk factors
  • electronic health record
  • current status
  • machine learning
  • adverse drug
  • combination therapy
  • case control
  • data analysis
  • artificial intelligence